文献速递淋巴瘤浆细胞疾病

致癌膜蛋白LMP1在B细胞淋巴瘤细胞中螯合TRAF3以产生功能性TRAF3缺陷

The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.
PubMed 文献 · Blood Adv · 2017-12-18

研究提出假说:LMP1可螯合TRAF3,减少其抑制B细胞促存活信号通路的可用性。通过比较人B细胞淋巴瘤细胞系中TRAF3调控事件与LMP1表达,以及分析转染可诱导型LMP1(野生型或TRAF3结合缺陷突变体)的小鼠B细胞淋巴瘤细胞系,结果显示表达LMP1的B细胞表现出与缺乏TRAF3基因的B细胞高度相似的表型。

要点

  • LMP1与TRAF3的结合效率高于CD40。
  • 表达LMP1的B细胞表现出与TRAF3基因缺失B细胞高度相似的表型。
  • LMP1可在无TRAF3基因突变的情况下使B细胞功能性TRAF3缺陷。

核心结论

  • LMP1可在无TRAF3基因突变的情况下使B细胞功能性TRAF3缺陷,该发现对B细胞恶性肿瘤的 pathway 靶向治疗选择具有相关性。

研究设计与样本

  • 通过2种互补方法验证假说:(1)比较人B细胞淋巴瘤细胞系中TRAF3调控的激活与存活相关事件与相对LMP1表达;(2)分析转染可诱导型LMP1(野生型LMP1或TRAF3结合缺陷突变体LMP1)的小鼠B细胞淋巴瘤细胞系亲本细胞与亚克隆配对中的上述事件。

主要发现

  • 近期对约300份人B细胞淋巴瘤组织样本的TRAF3蛋白染色分析显示,表达致癌性EB病毒编码蛋白LMP1的样本中TRAF3染色低/阴性的比例高于预期。
  • LMP1作为CD40受体的失调模拟物,与TRAF3的结合比CD40更有效。
  • 两种方法的结果均显示,表达LMP1的B细胞表现出与缺乏TRAF3基因的B细胞高度相似的表型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Loss-of-function mutations in genes encoding the signaling protein tumor necrosis factor receptor-associated factor 3 (TRAF3) are commonly found in human B-cell malignancies, especially multiple myeloma and B-cell lymphoma (BCL). B-cell TRAF3 deficiency results in enhanced cell survival, elevated activation receptor signaling, and increased activity of certain transcriptional pathways regulating expression of prosurvival proteins. A recent analysis of TRAF3 protein staining of ∼300 human BCL tissue samples revealed that a higher proportion of samples expressing the oncogenic Epstein-Barr virus-encoded protein latent membrane protein 1 (LMP1) showed low/negative TRAF3 staining than predicted. LMP1, a dysregulated mimic of the CD40 receptor, binds TRAF3 more effectively than CD40. We hypothesized that LMP1 may sequester TRAF3, reducing its availability to inhibit prosurvival signaling pathways in the B cell. This hypothesis was addressed via 2 complementary approaches: (1) comparison of TRAF3-regulated activation and survival-related events with relative LMP1 expression in human BCL lines and (2) analysis of the impact upon such events in matched pairs of mouse BCL lines, both parental cells and subclones transfected with inducible LMP1, either wild-type LMP1 or a mutant LMP1 with defective TRAF3 binding. Results from both approaches showed that LMP1-expressing B cells display a phenotype highly similar to that of B cells lacking TRAF3 genes, indicating that LMP1 can render B cells functionally TRAF3 deficient without TRAF3 gene mutations, a finding of significant relevance to selecting pathway-targeted therapies for B-cell malignancies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Bangalore-Prakash P, Stunz LL, Mambetsariev N, et al. The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency. Blood Adv. 2017. PMID: 29296923. doi:10.1182/bloodadvances.2017009670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。